Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

182 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The correlation between pre-treatment symptoms, acute and late toxicity and patient-reported health-related quality of life in non-small cell lung cancer patients: Results of the REQUITE study.
van der Weijst L, Azria D, Berkovic P, Boisselier P, Briers E, Bultijnck R, Chang-Claude J, Choudhury A, Defraene G, Demontois S, Elliott RM, Ennis D, Faivre-Finn C, Franceschini M, Giandini T, Giraldo A, Gutiérrez-Enríquez S, Herskind C, Higginson DS, Kerns SL, Johnson K, Lambrecht M, Lang P, Ramos M, Rancati T, Rimner A, Rosenstein BS, De Ruysscher D, Salem A, Sangalli C, Seibold P, Sosa Fajardo P, Sperk E, Stobart H, Summersgill H, Surmont V, Symonds P, Taboada-Valladares B, Talbot CJ, Vega A, Veldeman L, Veldwijk MR, Ward T, Webb A, West CML, Lievens Y; REQUITE consortium. van der Weijst L, et al. Among authors: lambrecht m. Radiother Oncol. 2022 Nov;176:127-137. doi: 10.1016/j.radonc.2022.09.020. Epub 2022 Oct 3. Radiother Oncol. 2022. PMID: 36195214 Free PMC article.
Reduction of the dose to the elective neck in head and neck squamous cell carcinoma, a randomized clinical trial using intensity modulated radiotherapy (IMRT). Dosimetrical analysis and effect on acute toxicity.
Nuyts S, Lambrecht M, Duprez F, Daisne JF, Van Gestel D, Van den Weyngaert D, Platteaux N, Geussens Y, Voordeckers M, Madani I, De Neve W. Nuyts S, et al. Among authors: lambrecht m. Radiother Oncol. 2013 Nov;109(2):323-9. doi: 10.1016/j.radonc.2013.06.044. Epub 2013 Aug 13. Radiother Oncol. 2013. PMID: 23953410 Clinical Trial.
LungTech, an EORTC Phase II trial of stereotactic body radiotherapy for centrally located lung tumours: a clinical perspective.
Adebahr S, Collette S, Shash E, Lambrecht M, Le Pechoux C, Faivre-Finn C, De Ruysscher D, Peulen H, Belderbos J, Dziadziuszko R, Fink C, Guckenberger M, Hurkmans C, Nestle U. Adebahr S, et al. Among authors: lambrecht m. Br J Radiol. 2015 Jul;88(1051):20150036. doi: 10.1259/bjr.20150036. Epub 2015 Apr 15. Br J Radiol. 2015. PMID: 25873481 Free PMC article. Clinical Trial.
Stereotactic body radiotherapy for central lung tumours: Author reply.
Adebahr S, Collette S, Shash E, Lambrecht M, Le Pechoux C, Faivre-Finn C, De Ruysscher D, Peulen H, Belderbos J, Dziadziuszko R, Fink C, Guckenberger M, Hurkmans C, Nestle U. Adebahr S, et al. Among authors: lambrecht m. Br J Radiol. 2015 Sep;88(1053):20150532. doi: 10.1259/bjr.20150532. Epub 2015 Jul 7. Br J Radiol. 2015. PMID: 26151618 Free PMC article. No abstract available.
Radiotherapy in combination with immune checkpoint inhibitors.
De Ruysscher D, Reynders K, Van Limbergen E, Lambrecht M. De Ruysscher D, et al. Among authors: lambrecht m. Curr Opin Oncol. 2017 Mar;29(2):105-111. doi: 10.1097/CCO.0000000000000352. Curr Opin Oncol. 2017. PMID: 28085679 Review.
Standard of care in high-dose radiotherapy for localized non-small cell lung cancer.
De Ruysscher D, Lambrecht M, van Baardwijk A, Peeters S, Reymen B, Verhoeven K, Wanders R, Öllers M, van Elmpt W, van Loon J. De Ruysscher D, et al. Among authors: lambrecht m. Acta Oncol. 2017 Nov;56(11):1610-1613. doi: 10.1080/0284186X.2017.1349337. Epub 2017 Aug 25. Acta Oncol. 2017. PMID: 28840754 No abstract available.
The EPTN consensus-based atlas for CT- and MR-based contouring in neuro-oncology.
Eekers DB, In 't Ven L, Roelofs E, Postma A, Alapetite C, Burnet NG, Calugaru V, Compter I, Coremans IEM, Høyer M, Lambrecht M, Nyström PW, Méndez Romero A, Paulsen F, Perpar A, de Ruysscher D, Renard L, Timmermann B, Vitek P, Weber DC, van der Weide HL, Whitfield GA, Wiggenraad R, Troost EGC; “European Particle Therapy Network” of ESTRO. Eekers DB, et al. Among authors: lambrecht m. Radiother Oncol. 2018 Jul;128(1):37-43. doi: 10.1016/j.radonc.2017.12.013. Epub 2018 Mar 13. Radiother Oncol. 2018. PMID: 29548560 Free article. Review.
Radiation dose constraints for organs at risk in neuro-oncology; the European Particle Therapy Network consensus.
Lambrecht M, Eekers DBP, Alapetite C, Burnet NG, Calugaru V, Coremans IEM, Fossati P, Høyer M, Langendijk JA, Méndez Romero A, Paulsen F, Perpar A, Renard L, de Ruysscher D, Timmermann B, Vitek P, Weber DC, van der Weide HL, Whitfield GA, Wiggenraad R, Roelofs E, Nyström PW, Troost EGC; work package 1 of the taskforce “European Particle Therapy Network” of ESTRO. Lambrecht M, et al. Radiother Oncol. 2018 Jul;128(1):26-36. doi: 10.1016/j.radonc.2018.05.001. Epub 2018 May 17. Radiother Oncol. 2018. PMID: 29779919 Review.
RNA-sequencing in non-small cell lung cancer shows gene downregulation of therapeutic targets in tumor tissue compared to non-malignant lung tissue.
Reynders K, Wauters E, Moisse M, Decaluwé H, De Leyn P, Peeters S, Lambrecht M, Nackaerts K, Dooms C, Janssens W, Vansteenkiste J, Lambrechts D, De Ruysscher D. Reynders K, et al. Among authors: lambrecht m. Radiat Oncol. 2018 Jul 17;13(1):131. doi: 10.1186/s13014-018-1075-1. Radiat Oncol. 2018. PMID: 30016964 Free PMC article.
182 results